Dr. Sharmistha Ghosh-Janjigian serves as a Program Director for the Cancer Biomarkers Research Group (CBRG). Her portfolio includes various initiatives in risk assessment, detection, diagnosis and prognosis of early cancer. Dr. Ghosh-Janjigian provides scientific/programmatic leadership to the following: PreCancer Atlas (PCA) Research Centers (part of the Human Tumor Atlas Network; developed under the auspices of the Cancer Moonshot^SM); Pancreatic Cancer Detection Consortium (PCDC); Early Detection Research Network (EDRN); and Molecular and Cellular Characterization of Screen-Detected Lesions (MCL) Consortium. In addition, she is involved in the activities of Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer (CPDPC) (with National Institute of Diabetes and Digestive and Kidney Diseases [NIDDK]). Dr. Ghosh-Janjigian also serves as a Divisional representative in many trans-NCI scientific initiatives/meetings.

Dr. Ghosh-Janjigian earned her undergraduate and graduate degrees from Presidency College/University of Calcutta and Jawaharlal Nehru University in India and conducted postgraduate research at the Beth Israel Deaconess Medical Center/Harvard Medical School in Boston. Her research background in molecular biology and immunology includes transcription factor mapping and study of morphogenetic pathways and virulence in Candida albicans, regulated secretion of clinical biomarker ferritin, study of cannabinoids, immune system and breast cancer, and DNA vaccine studies. Prior to joining the Division of Cancer Prevention in 2013, Dr. Ghosh-Janjigian served as a Scientific Editor for Biochimica et Biophysica Acta and a Senior Editor for Journal of the National Cancer Institute.